Search results for: hospital

Interleukin 17 Inhibitors Promising in Ankylosing Spondylitis Patients

Michele B. Kaufman, PharmD, BCGP | July 10, 2020

In patients with active ankylosing spondylitis, IL-17 inhibitors have produced favorable responses, according to recent research…

ACR Releases Clinical Guidance for Patients with Multisystem Inflammatory Syndrome in Children

Gretchen Henkel | July 8, 2020

The recommendations for MIS-C focus on general guidance, diagnostic evaluation and therapy options, as well as comparing and contrasting the features of MIS-C and Kawasaki disease.

ACR Releases COVID-19 Clinical Guidance for Pediatric Patients with Rheumatic Disease

Gretchen Henkel | July 8, 2020

The recommendations for pediatric rheumatology patients address various treatment options and provide general guidance, as well as direction for when to start, stop or reduce medications.

Bone Density Concerns: Guidance on Tackling Fracture Risk in CKD

Thomas R. Collins | July 7, 2020

Suggestions on how to assess risk and manage bone issues in chronic kidney disease patients are offered…

Biologic Treatment Recommendations for Rheumatic Disease Patients Who Contract COVID-19

Thomas R. Collins | July 7, 2020

COVID-19 Global Alliance registry and other data on rheumatic disease patients with COVID-19 were presented…

Caring for Pediatric Patients During a Pandemic: Q&A with Jay Mehta, MD

Mary Beth Nierengarten | July 6, 2020

Caring for pediatric patients during a pandemicin the age of COVID-19 requires adaptations, says Jay Mehta, MD, Children’s Hospital of Philadelphia. “The one exposure that seems to put [pediatric] patients at risk is if they are on higher doses of steroids, with some data suggesting worse outcomes. We just put out guidelines telling providers to reduce steroids in their patients to the lowest dose that can adequately control their disease.”

The ACR Releases New Telemedicine Position Statement

Carina Stanton | July 6, 2020

The rapid expansion of telemedicine in rheumatology, as well as changes to reimbursement and relaxed regulations, during the COVID-19 pandemic has served as an impetus for the ACR to review its position and release a new statement in support of optimized telemedicine practices.

Apremilast Promising for Plaque Psoriasis

Michele B. Kaufman, PharmD, BCGP | July 6, 2020

Apremilast has been shown to improve the signs and symptoms of mild to moderate plaque psoriasis in adults, according to new research…

In Memoriam … J. Timothy Harrington, MD, MACR: July 6, 1940–June 23, 2020

William Arnold, MD; Tim Bartholow, MD; Drew Johnson, MS, MBA; Joel Kremer, MD; Daniel Malone, MD; Eric D. Newman, MD; Kenneth Saag, MD; & Douglas White, MD | June 30, 2020

June saw the passing of a beloved colleague, mentor and friend to many in the rheumatology community when J. Timothy Harrington, MD, died of pancreatic cancer in his hometown of Madison, Wis. Dr. Harrington trained at Massachusetts General Hospital, the National Institutes of Health National Cancer Institute and UT Southwestern Medical Center, and served on…

ABX464 in Phase 2a Trials for RA

Michele B. Kaufman, PharmD, BCGP | June 29, 2020

Research is examining the safety and tolerability of two different doses of ABX464 in patients with moderate to severe active RA…